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ABSTRACT
Background: It is unknown if universal second-trimester transvaginal ultrasound (TVU) cervical
length (CL) screening in asymptomatic women with singleton gestations and no prior spontan-
eous preterm birth (SPTB) affects the incidence of symptoms of preterm labor (PTL) later in
pregnancy.
Objective: To evaluate the incidence of threatened PTL before and after the implementation of
universal second trimester TVU CL screening.
Study design: This was a retrospective cohort study of all consecutive singleton gestations with-
out prior SPTB presenting to obstetric triage for threatened PTL between 23 0/7 and 33 6/7
week in 2011 (1 January–31 December), and in 2014 (1 January–31 December) at Thomas
Jefferson University Hospital (TJU) (Philadelphia, PA). These 2 years were chosen as a new proto-
col for universal TVU CL screening was started on 1 January 2012. This protocol involved one
measurement of TVU CL in all singleton gestations without a prior SPTB at 18 0/7 23 6/7 week,
the time of the “anatomy” scan. Women with prior SPTB were excluded from this study. The pri-
mary outcome included the incidence of threatened PTL, defined as the number of women with
singleton gestations without prior SPTB who presented with threatened PTL to our labor and
delivery (L&D) triage unit annually, divided by the total number of annual deliveries of women
with singleton gestation without prior SPTB. Secondary outcomes were the incidence of PTL,
defined as the number of women with singleton gestations without prior SPTB admitted for PTL
annually divided by the total number of annual deliveries of women with singleton gestation
and without prior SPTB; and length of stay in the hospital. We aimed to compare primary and
secondary outcome in the “2011” versus the “2014” group.
Results: In 2011, there were a total of 1745 deliveries at TJU, of which 1550 (88.8%) were single-
tons without prior SPTB. In 2014, there were a total of 1924 deliveries at TJU, 1751 (91.0%) were
singletons without prior SPTB who were offered universal TVU CL screening. One hundred and
seventy-two women with singletons without prior SPTB presented in L&D triage unit in 2011;
and 118 women with singletons without prior SPTB presented in L&D triage unit in 2014. There
were significant decreases in the incidence of threatened PTL from 11.1% (172/1550) in 2011 to
6.7% (118/1751) in 2014 (p< .001), as well as in the rate of admission for PTL from 2.3% (35/
1550) to 1.4% (24/1751), respectively (p¼ .04). Length of stay was not significantly different
between the two groups.
Conclusion: The introduction of a universal TVU CL screening program in women with singleton
gestations without a history of SPTB is associated with a reduction in the frequency of threat-
ened PTL and admission for PTL.
KEY MESSAGE
 The introduction of a second trimester universal transvaginal ultrasound (TVU) cervical length
(CL) screening program in women without a history of spontaneous preterm birth (SPTB) is asso-
ciated with a reduction in the incidence of threatened preterm labor (PTL) and admission for PTL.
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Introduction
Preterm birth (PTB) is the leading cause of perinatal
morbidity and mortality [1]. Worldwide, about 15
million babies are born too soon every year, causing
1.1 million deaths [2].
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Different strategies have been adopted for the pre-
vention of PTB. The evidence supports the use of vagi-
nal progesterone in singleton gestations without prior
spontaneous PTB (SPTB) who develop short transvagi-
nal ultrasound (TVU) cervical length (CL) before 24
weeks [3,4]. Based on this evidence, universal TVU CL
screening at around 18–23 6/7 week has been pro-
posed for all singleton gestations without prior SPTB,
with one TVU CL measurement at the time of the
anatomy scan at about 18 0/7 23 6/7 week [3–11].
It is unknown if second-trimester TVU CL screening
in asymptomatic women affects the incidence of symp-
toms of preterm labor (PTL) later in pregnancy. Indeed,
early identification and treatment of women at risk of
SPTB, such as women with asymptomatic short TVU CL,
may decrease the risk of these women later having
symptoms of PTL, or PTL, in addition to decreasing the
risk of subsequent SPTB [8]. PTL is one of the common
indication for admission in the second and third trimes-
ter, thus the importance of any intervention that may
decrease this frequent reason for hospital evaluation
and admission cannot be underestimated.
Our objective was to evaluate the incidence of
threatened PTL before and after the implementation
of universal second trimester TVU CL screening.
Materials and methods
Study design
We conducted a retrospective cohort study of all con-
secutive singleton gestations without prior SPTB pre-
senting to obstetric triage for threatened PTL between
23 0/7 and 33 6/7 week in 2011 (1 January – 31
December), and in 2014 (1 January – 31 December) at
Thomas Jefferson University Hospital (TJU)
(Philadelphia, PA). Multiple gestations and women
with prior SPTB were excluded. These 2 years were
chosen as a new protocol for universal TVU CL screen-
ing was started on 1 January 2012 [6]. This protocol
involved one TVU CL screen of all singleton gestations
without a prior SPTB at 18 0/7 23 6/7 week, the time
of the “anatomy” scan (Figure 1). The CL was meas-
ured by operators with certification of competence in
the technique (CLEAR). The length of the cervix was
measured with a transvaginal real-time ultrasound
probe placed in the anterior fornix of the vaginal.
Endocervical canal length was measured as the dis-
tance between the internal and external os, by using a
straight line with calipers placed at the notches made
by the internal os and external os. Three anatomic
landmarks defined the appropriate sagittal view: the
internal os, the external os and the endocervical canal.
The image was enlarged while visualizing the
three landmarks simultaneously. This procedure was
repeated three times. After a baseline CL was meas-
ured, the fundal pressure was applied for 30 s as a pro-
vocative maneuver. CL was measured during and after
the fundal pressure. Only the shortest CL measure-
ment was recorded. Each examination was performed
during a minimum of 5min.
Women without prior SPTB identified to have a TVU
CL 20mm were offered daily 90mg vaginal proges-
terone gel, or if the vaginal gel could not be obtained
from the patient’s insurance company, daily 200mg
micronized natural progesterone gel capsules were
offered (Figure 1).
Women who presented to obstetric triage for
threatened PTL were identified though labor and deliv-
ery (L&D) records (our triage book), medical records,
and billing records. Threatened PTL was defined as
any symptoms of possible uterine contractions, includ-
ing abdominal cramps, low back pain, pelvic pressure,
or bloody show, for which the woman presented to
our L&D triage unit. Women with threatened PTL were
evaluated according to an approved clinical guideline
[12] (Figure 2). PTL was defined as threatened PTL
with short TVU CL  20mm, or TVU CL 21–29mm and
positive fetal fibronectin (FFN). This guideline recom-
mends intervention for PTL (i.e. admission, tocolysis,
and steroids) for women with TVU CL  20mm and
for those with TVU CL 21–29mm and a positive FFN,
and discharge for women with threatened PTL but
with TVU CL 30mm [12] (Figure 2). This protocol was
started on November 2013, while before this date the
decision for admission and interventions for women
with threatened PTL was at physician’s discretion
based on serial digital exams.
Figure 1. Clinical management algorithm for the universal cer-
vical length screening program for asymptomatic singleton
gestations.
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Primary and secondary outcomes
The primary outcome included the incidence of threat-
ened PTL in singleton gestations without prior SPTB,
defined as the number of women with singleton gesta-
tions without prior SPTB who presented with threat-
ened PTL to our L&D triage unit annually, divided by
the total number of annual deliveries in singletons
without prior SPTB at our institution. Secondary out-
comes were the incidence of PTL in women with single-
ton gestation without prior SPTB (admitted for PTL
annually), divided by the total number of annual deliv-
eries in singletons without prior SPTB at our institution.
We aimed to compare the primary and the secondary
outcome in the “2011” versus the “2014” group.
Statistical analysis
Statistical analysis was performed using Statistical
Package for Social Sciences (SPSS) v 19.0 (IBM Inc.,
Armonk, NY). Differences between groups were
analyzed using chi-square test and Fisher’s exact test
for categorical variables and Student’s t-test or
Mann–Whitney test for normally and non-normally
distributed continuous variables, respectively. A two-
tailed p value of .05 or less was considered significant.
This study was approved by the Thomas Jefferson
University Institutional Review Board Control #15D.221
JeffTrial # 7737.
Results
In 2011, there were a total of 1745 deliveries at TJU, of
which 1709 (97.9%) were singletons, and 1550 (88.8%)
were singletons without prior SPTB. In 2014, there
were a total of 1924 deliveries at TJU, of which 1889
(98.2%) were singletons, and 1751 (91.0%) were single-
tons without prior SPTB.
In 2011, 172 women with singletons gestations and
without prior SPTB presented in L&D triage unit for a
total of 178 visits; while 118 women with singleton
gestations without prior SPTB presented in L&D triage
unit in 2014 for a total of 121 visits (Figure 3).
Table 1 shows the characteristics of the women
with threatened PTL. There were no significant differ-
ences in maternal age, parity, and the race between
the 2011 and 2014 groups of women who presented
with threatened PTL.
There were significant decreases in the incidence of
threatened PTL from 11.1% (172/1550) in 2011 to 6.7%
(118/1751) in 2014 (p< .001), as well as in the rate of
admission for PTL from 2.3% (35/1550) to 1.4% (24/
1751), respectively (p¼ .04). Length of stay was not
significantly different between the two groups
(Table 2).
Discussion
This study aimed to evaluate the incidence of threat-
ened PTL before and after the implementation of uni-
versal second trimester TVU CL screening in singleton
gestations without a prior SPTB. We found significant
decreases in the incidences of visits to L&D triage due
to threatened PTL and of admission to L&D for PTL
comparing data at our institution in 2011, before uni-
versal TVU CL screening, to 2014, after implementation
Figure 3. Study flowchart. PTL: preterm labor; PTB: preterm
birth.
Figure 2. Clinical management algorithm for women with
threatened preterm labor presenting in triage. TVU CL: transva-
ginal ultrasound cervical length; FFN: fetal fibronectin.
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of universal TVU CL screening. These decreases can be,
at least partially, explained by the introduction on
1 January 2012 of universal second trimester TVU CL
screening in asymptomatic singleton pregnancies with-
out prior SPTB, with treatment with vaginal progester-
one for those with short CL. The incidence of short
TVU CL, defined as TVU CL 20mm, in the screened
women in 2014 was 12.7% among those who devel-
oped threatened PTL later in gestation (Table 1).
This study has several limitations. The most import-
ant one was the retrospective nonrandomized study
design. Because of its retrospective nature, it was not
possible to separate the effect of the screening versus
other variables, such as other management interven-
tions. However, there were no other changes in man-
agement in PTB preventions between 2011 and 2014
in our institution apart from the introduction of uni-
versal TVU CL screening, except for the introduction in
November 2013 of a protocol using TVU CL (and FFN
as necessary) for triaging women presenting for threat-
ened PTL [12,13]. This other new protocol could have
decreased further the incidence of PTL, but could not
have influenced our primary outcome, i.e. the inci-
dence of threatened PTL. Our study lacks of data
regarding important maternal demographics, such as
smoking or BMI, and regarding gestational age at
delivery, PTB, and neonatal outcomes. We used
20mm as cut-offs for vaginal progesterone,
while now in 2017 we have started using 25mm
based on new 2017 data [4]. We did not evaluate ther-
apy or management of women with PTL or of those
with arrested PTL after threatened PTL. So far, no ther-
apy [14–25], including cerclage [14,19,21,24], proges-
terone [15,16], or cervical pessary [17,18], as well as
diet or antenatal supplementation [20,22,25] have
been shown to be effective in women with PTL or
with arrested PTL, neither in singletons nor in twins.
We did not evaluate the antenatal lifestyle of the
included women. Several studies have been shown
that exercise during pregnancy may reduce the risk of
PTB [26–28].
Our study has some strength, including the single
institution study design, with the unified protocol for
the management of universal second trimester TVU CL
screening, vaginal progesterone and management in
triage guided by a protocol for women with threat-
ened PTB. The main strength of our study is that there
is limited information in the literature on the effect of
second trimester universal TVU CL screening in asymp-
tomatic women with singletons without a prior SPTB
on the incidence of symptoms of PTL later in preg-
nancy. Several studies [6–11] have evaluated the effect
of the introduction of universal TVU CL screening in
women without prior SPTB, showing decreases in PTB
after implementation [7], but only one study looked at
the incidence of PTL. Son et al. in a large cohort of
women with singleton gestations without any prior
PTB showed that the introduction of a universal TVU
CL screening program was associated with a reduction
in the incidence of PTB, while the incidence of threat-
ened PTL and PTL were not evaluated [7]. The inci-
dence of threatened PTL and PTL was also not
reported on other studies on universal TVU CL screen-
ing [6,9–11]. Shaniker et al. is the only prior study
which aimed to evaluate the effect of a universal TVU
CL screening program on the incidence of PTB and of
antepartum intervention, and which reported on PTL.
They found that women who had universal TVU CL
screening had less PTL admissions (2.3%) compared to
women who did not have a CL measurement done
(7.4%) [8]. They did not report on the incidence of
threatened PTL [8]. Their findings concur with our
results.
In summary, based on this retrospective study, fol-
lowing the implementation of universal CL screening
with the treatment of short cervix with vaginal proges-
terone, there was a reduction in the frequency of
threatened PTL and admission for PTL.
Table 1. Characteristics of women with singleton gestations without prior spontaneous preterm birth
with threatened preterm labor in 2011 and in 2014.
No TVU CL universal
screening (2011) N¼ 172
TVU CL universal
screening (2014) N¼ 118 p value
Maternal age 27.3 ± 4.7 27.1 ± 5.1 .67
African American race 100 (58.1%) 70 (59.3%) .72
Nulliparity 76 (44.2%) 51 (43.2%) .81
TVU CL 20mm at TVU CL screening ND 15 (12.7%) –
Vaginal progesterone 0 15 (12.7%) –
TVU CL: transvaginal ultrasound cervical length; d: not done.
Table 2. Primary and secondary outcomes.
2011 N¼ 1550a 2014 N¼ 1751a p value
Threatened PTL 172 (11.1%) 118 (6.7%) <.001
Admitted for PTL 35 (2.3%) 24 (1.4%) .04
LOS 4.4 ± 3.7 4.6 ± 4.2 .15
PTL: preterm labor; PTB: preterm birth; LOS: length of stay.
aOnly singleton gestations without prior spontaneous preterm birth (PTB).
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